Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies

Parody, 2009, Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes, Am J Hematol, 84, 571, 10.1002/ajh.21488 Ramos, 2011, Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles, Oncologist, 16, 1049, 10.1634/theoncologist.2010-0290 Herbrecht, 2002, Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis, N Engl J Med, 347, 408, 10.1056/NEJMoa020191 Walsh, 2008, Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America, Clin Infect Dis, 46, 327, 10.1086/525258 Freemantle, 2011, Systematic review and mixed treatment comparison of randomized evidence for empirical, pre-emptive and directed treatment strategies for invasive mould disease, J Antimicrob Chemother, 66, i25, 10.1093/jac/dkq439 Herbrecht, 2010, Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: a European Organisation for Research and Treatment of Cancer study, Bone Marrow Transplant, 45, 1227, 10.1038/bmt.2009.334 Maertens, 2004, Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy, Clin Infect Dis, 39, 1563, 10.1086/423381 Viscoli, 2009, An EORTC phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients, J Antimicrob Chemother, 64, 1274, 10.1093/jac/dkp355 Perea, 2002, In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp., Antimicrob Agents Chemother, 46, 3039, 10.1128/AAC.46.9.3039-3041.2002 Kirkpatrick, 2002, Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis, Antimicrob Agents Chemother, 46, 2564, 10.1128/AAC.46.8.2564-2568.2002 Petraitis, 2003, Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin, J Infect Dis, 187, 1834, 10.1086/375420 Marr, 2004, Combination antifungal therapy for invasive aspergillosis, Clin Infect Dis, 39, 797, 10.1086/423380 Maertens, 2006, Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis, Cancer, 107, 2888, 10.1002/cncr.22348 Singh, 2006, Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study, Transplantation, 81, 320, 10.1097/01.tp.0000202421.94822.f7 De Pauw, 2008, Clin Infect Dis, 46, 1813, 10.1086/588660 Arikan, 2002, In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp., Antimicrob Agents Chemother, 46, 245, 10.1128/AAC.46.1.245-247.2002 Sionov, 2006, Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis, J Infect, 53, 131, 10.1016/j.jinf.2005.10.015 Kontoyiannis, 2003, Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies, Cancer, 98, 292, 10.1002/cncr.11479 Mihu, 2010, Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?, Cancer, 116, 5290, 10.1002/cncr.25312 Bonatti, 2010, Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin, Mycoses, 53, 448, 10.1111/j.1439-0507.2009.01729.x Thomas, 2010, Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis, J Clin Pharm Ther, 35, 49, 10.1111/j.1365-2710.2009.01061.x Yilmaz, 2011, A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections, Mycoses, 54, 234, 10.1111/j.1439-0507.2009.01808.x Marr, 2012, A randomized, double-blind study of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis Marr, 2002, Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors, Blood, 100, 4358, 10.1182/blood-2002-05-1496